Reconciled PDUFA bill omits REMS provision
14:48 EDT 18 Jun 2012 | BioCentury
Congress released late Monday a reconciled PDUFA reauthorization bill that excludes a pay-for provision in the Senate version of the bill that would have reduced marketing barriers for generics and biosimilars. The provision, opposed by the Pharmaceu..
Original Article: Reconciled PDUFA bill omits REMS provision
More From BioPortfolio on "Reconciled PDUFA bill omits REMS provision"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
